Crossmark

Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective study

Crossref DOI link: https://doi.org/10.1007/s10096-017-3037-1

Published Online: 2017-07-26

Published Print: 2017-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

van Gorkom, T.

Kremer, K.

Voet, W.

Notermans, D. W.

Vlaminckx, B. J. M.

Sankatsing, S. U. C.

Thijsen, S. F. T.
Funding

Funding for this research was provided by:

The Ministry of Health, Welfare and Sports

The Medical Specialist Company Domstad U.A. (MSBD)
License Information

License valid from 2017-07-26

Document is current

Any future updates will be listed below